VFF

SuzyCreamcheezies

Totally agree. This sub has always been hung up on a "tier-1 or nothing" mentality, not recognizing that other viable options exist. Picking up some private companies across multiple states is an interesting idea and would be nice way to get their foot in the door. I assume this would be far cheaper than negotiating with tier-1/2 companies for a buyout or merger. The argument is often that they can't compete (or dominate, lol) against the likes of Green Thumb or Trulieve (for example), but they don't have to on day-one. Most have decent revenue in Canada/international and this would be another addition to their portfolio. I still get the feeling that some LPs will lean more towards the supply, distribution and brand side of things if legislation allows (interstate commerce). For example, VFF could leverage their Texas greenhouses for their own products or white label partnerships. Tilray clearly has plans for hemp and distribution (as you have pointed out numerous times), and seem to be focusing heavily on medical as of late, so I could see them continuing with beverages while pursuing a larger medical partnership. And/or MedMen branded products instead of brick and mortar. I wonder if they have any optionality on MedMen's previous production facilities.

Humungusminimaglight

VFF also have Balanced Health Botanicals (BHB) in US and it will be interesting to see how they utilize that.

SuzyCreamcheezies

Canopy has Acreage and SNDL has Sunstream. I think Cronos has some level of MSO investment and Tilray *may* have some California licenses from the MedMen bankruptcy. I'm very curious how the "broader rescheduling" will shake out over the summer. LPs are generally not retail operators and I wonder if some (looking at VFF and Texas) are hoping for conditions that allow for interstate commerce so that they can function more closely to how they do in Canada and international. Be part of the supply chain and product creation, but without the retail component.

Tommygun194

$VFF

ImplementThese8486

Time to load up on VFF stock

Ok-Replacement9595

Sold some VFF for 10% to get in on the TCNNF dip. Their next earnings without 280e will be worth it.

Worried_Quarter469

Village Farms International (VFF) — the largest publicly traded North American greenhouse tomato grower, with operations in Texas and British Columbia. A US-based grower actually benefits from the Mexico tomato tariff since it competes with those imports. Caveat: the equity story is now dominated by their cannabis segment, so you’re not getting a clean tomato bet. Village Farms is one of North America’s largest publicly traded greenhouse tomato producers

volckerwasright

If you have a Twitter, ask this guy your questions, Shane Pennington. He's an administrative law attorney who represented VFF in the rescheduling proceedings, great guy. There are also people who post here like Gambelero who have a ton of background on the subject. https://x.com/admindotlaw

MatrixOrigin

SNDL, HITI and VFF. I was for sure expecting a TLRY pump 😂

FoodCooker62

Here's a fun comparison and shows why this sector is, as the young kids say, "cooked": Canopy growth market cap: 534 million Combined Auxly + VFF: 470 million Earnings before taxes - last twelve months: Canopy growth: (58,8 million) Auxly + VFF: 44,9 million Almost 100 million more in annual profitability despite a lower combined market cap. Keeping zombie meme companies alive is the cannabis sectors specialty. This is why weed stocks are a joke.

NoOcelot

Just massive news from Auxly. VFF is the only other LP I'm aware of that's done a share buyback. But Auxly is more profitable.

Kbarbs4421

I haven't spread Auxly alongside Cronos or VFF but I'm reasonably confident t that your assumption here is off base. My guess is that the three comp reasonably well.

confidentbeaver

VFF is net income positive as well

gdren

VFF and CRONOS have done them

HugeDramatic

Not saying there aren’t any creative solutions, but on paper it doesn’t look great. If I were VFF management I’d be getting in touch with some of the Phase I or Phase II license holders and asking about joint venture potential.

SuzyCreamcheezies

But so much of VFF's story and appeal has been the turnkey Texas greenhouses they already own. Not the end of the world, but a *pretty big* setback.

HugeDramatic

https://www.dps.texas.gov/news/dps-update-phase-ii-texas-compassionate-use-program-expansion-selection-process The way I read it is that Green Thumb, Cresco or Texas Medica will need to fail to mobilize in order for one of the 12 waitlisted companies including VFF to have a chance at a license. Since I doubt that will occur, VFF is likely dead in the water in Texas. That said, I don’t think it’s the end of the world. VFF will just have to pivot its strategy into more European focus and maybe target another state to buy out a company with an existing license.

No_Love_Gained

Cresco gets their Texas licence. Any news on VFF?

mfairview

BAT and VFF? not bloody likely. where do you see anything remotely close to that assertion?

bourbonwarrior

BAT now owns big chunks of OGI-CWEB and VFF Big time ex-BAT executives populate top positions at 2 of the 3 firms BAT is a 126B firm

UsedState7381

They also have near 500k shares of VFF, I know that VFF is mainly a Canadian operator, but MSOS owns a bunch of it soo... We gotta prepare for MSOS to be sub $3 by next week now...And the good news is that last time we broke $3, we started to shoot up afterwards in the rumours of the executive order.

the_mammynun

He mentioned they'll be rolling out a roster of Canadian Brands in June who will be selling exclusively through Remexian in the German and UK markets. If I had to guess it will be all the big boys (TLRY, ACB, VFF, CGC) and a few smaller players like LOVE trying to build a bigger international precense.  The largest exception will be OGI as they have their own importer in Germany, and CRON is a wild card because they do have CanAdelaar in the Netherlands.. I can't speak to their ability to leverage that for German imports. He also mentioned that Nuleaf Naturals is GMP and FDA certified and meets all the requirements for the CBD Medicare pilot. Sounds like there's a good chance they'll be able to partake in that right out of the gates. He cautioned that revenue growth should be expected there until 2027/2028, not sure why.  Also, it seems that importing to Germany from Canada is proving more time consuming that originally thought, since our first shipment expected the first week of March is now expected to be 30 days late. However we have been successful in importing product from South Africa, Thailand, Malta, and Czech Republic recently.

Forest_City_Frolfer

When CGC, TLRY, or ACB start positive positive net income the tune will change. XLY and VFF have been funding their operations through operating cash flow recently and that deserves some recognition. It's a huge accomplishment in this sector, and very good for shareholders.

skyplt29

understood....VFF same?

skyplt29

Hmmmm...I note VFF and Tilray are on a different path than the market...not large gains, but somewhat contrary to the others. Volume is not there however. Starting to look for news that might explain.

skyplt29

Taco Donnie just upended that with a five day delay on attacking Iran's energy infrastructure. Just impossible to keep up. Watched VFF go from -4% premarket, to +7%, and now back to -3%. Wacky times. I had three trips planned over the next month. Just cancelled them all. The idea of ICE agents replacing TSA is a bit over the top for me. Time to shelter in place.

Tiaan

> Clinics/Doctors have to form partnerships with suppliers and its the clinics that get they $500 rebate to buy product to give to their patients. CWEB is involved in way more associations and trials than anybody else but VFF is doing work in that space with clinical trials, having people on their board and such. I don't think many people who were hyping up this program realized that this is how the rebates were going to work. I saw many people specifically hyping CWEB with messaging like "they're going to be the sole supplier for the pilot that will eventually result in millions of seniors being reimbursed for their CBD and a run rate for CWEB of over $1b in sales." But the reality, like you said, is that it will be limited healthcare facilities being able to offer CBD products to their patients and possibly be reimbursed up to $500/patient if they can demonstrate that these products reduced their overall cost of healthcare and improved outcomes under strict CMS oversight. There's many companies selling federally compliant hemp derived products today. My parents regularly order CBD products from two of them and neither of them are CWEB, VFF or even a publicly traded company. I may have been mistaken, but I had an impression that there were going to be select suppliers approved by CMS to participate in the program (such as CWEB), but that doesn't seem to be the case either based on their most recent guidance, which seems to extend eligibility to any federally compliant hemp derived product

hambone_83

Had some time to kill this morning so decided to educate myself as best as possible on this pilot program. Also wanted to do more research to see how my investment pick for playing this opportunity (VFF) is aligned vs competitors. This is my research so do your own due diligence: * Charlottes Web seems the best situated to win early on. They have a federal partnership with CMS and have the most robust turn key solution for clinics/doctors. Basically a doctor fills out a form and setups a portal and they are given information and product recommendations to start right away with little effort on their part. They are also the biggest player in the space (grow capacity) * VFF (CBDistillery) has its own turn key setup for clinics but its not as robust as CWEB. This makes sense as VFF has many irons in the fire (Canada, Europe, now this) while this program is a big deal for CWEB so they would put more effort here. VFF also only has a 25K facility which is on the smaller end * Clinics/Doctors have to form partnerships with suppliers and its the clinics that get they $500 rebate to buy product to give to their patients. CWEB is involved in way more associations and trials than anybody else but VFF is doing work in that space with clinical trials, having people on their board and such. * CWEB products are priced at the higher end of the market and VFF products come in around 20-40% cheaper from what I could find. For example comparing CBD capsules the $500 threshold would but 4 bottles of CWEB but 10 bottles of VFF (same amount of CBD in each bottle - different dosage per capsule) * Of note, there are a number smaller private players around the US that are even cheaper than VFF - which also have the same GMP & hemp certifications and go through the proper testing requirements. My opinion, CWEB should have the biggest boost right away as they are the most well known, have the strongest partnerships plus can deliver the most supply. But will be interesting to see how the landscape evolves. Since its the clinics purchasing the products for clients, I would assume they would eventually migrate to cheaper products to give more medicine for the $500 (not caring about what brand they are using). As long as they feel confident the product is safe, tested and works. Interesting to learn, don't make this a key driver to your investing choices and not financial advice

skyplt29

Painful...just painful at this point. Only thing that is stopping me from selling is the fact other LPs are similar...VFF at -4% and WEED at -4.29%. It's been three months of misery since that EO was signed on 18 Dec. Appreciate this war with Iran is causing oil to spike and having a major impact on markets...but getting some good news in this sector seems impossible.

TomorrowLow5092

I agree and added VFF to your mix. They are a big producer of flower in multiple countries.

SuzyCreamcheezies

To be fair, none of Tilray’s recent acquisitions have been in the cannabis space. Nor do they need any more brands or capacity in Canada. With that said, it looks like OGI, VFF and Tilray have all claimed the lead in flower sales within recent months. I don’t expect any to take a substantial lead without further consolidation in the Canadian market.

dreamgreener

VFF dropped fast I was mulling over it at 3.21 cdn but thought twice about selling Cura or Cresco because they’ve bottomed out already and I can see myself losing more with VFF or CWEB

the_mammynun

For the time being VFF will continue to benefit, they're doing great. And yeah that's definitely a major risk for retailers. 

the_mammynun

Like I said, VFF is an efficient operator, so is LOVE. They are the exceptions not the rule when talking about growers. HITI generated $12m cad FCF in the entire year, but they reinvest a lot in working capital. They opened 27 new stores organically and bought a German distributor this year.  All I'm saying is long term HITI has more stable growth avenues. VFF will always be a grower and that makes them sensative to commoditization risk as global supply opens further. HITI will be there to manage distribution and sales no matter who is supplying the market.

gdren

I mean... cool theory but I'm looking at the cash flow numbers and it sure seems like the producers are generating the majority of the cash flow at this point in Canada. VFF just generated $15m USD this past quarter from their Canadian operations. How much did HITI generate?

FoodCooker62

Just in flower. OGI claims overall market share. Vapes & pre-rolls are a growing portion of overall market size. I dont think pre-rolls are part of flower because VFF isnt very strong in pre rolls. 

the_mammynun

Like I said VFF is an efficient operator, I just don't see the value long term in growing cannabis. HITI's ecosystem, despite lower margins today is a much larger opportunity in my opinion because they define the shopping experience and can generate high margin revenue streams from data sales, shelf space, advertisement, in-house brands, paid membership, etc.. all while becoming a household name for the consumer and a must-have partner for every LP in Canada. When you consider Remexian and the global import/export market , HITI's opportunity for sales and margin growth becomes even more pronounced. They are positioning themselves as a critical piece to the success of the entire industry. In time, they will be invaluable. 

pincandies

ah yes, VFF is your holding... I guess trashing LPs like CGC TLRY SNDL didn't help your cause lol

NoOcelot

SNDL and VFF are the only two LPs I know of that are buying back shares.

GeoLogic23

Don't you constantly say Tilray is way way overvalued? Why even compare VFF to such an overvalued company? I assume VFF has better multiples compared to other companies, given your constant complaining about Tilray's valuation. And over the past year VFF share price has absolutely blown Tilray out of the water. So the market is clearly rewarding them. Not fast enough for you?? One red day doesn't change their clear upward trajectory and separation from pretty much every other cannabis company, including Tilray.

FoodCooker62

VFF's stock has recovered but has in no way shape or form a valuation premium attached to its performance. Even now VFF's EV/sales is lower than tilrays while they have outstanding cash generation and the latter only burns cash and dilutes. Its stock is still severely lagging.

GeoLogic23

VFF is up over 300% in less than a year... People keep claiming this whole sector is broken, but VFF is one of the easiest to point to examples of the fact that financials matter. They are one of the most solid LPs, and their stock price has clearly shown that. So it's down 10% today? Just zoom out and compare them to any other company in our sector not named CWEB.

UsedState7381

Insane overreaction on VFF unless there's something else we are all missing about the earnings report.

skyplt29

Watched Joe Rogan's recent podcast. I have mixed feelings about it. This guy supported Trump in 2024 and is now expressing "surprise and disappointment" that Trump pretty much lied about everything. Not sure why Rogan is now just seeing that. You have to question why he did not see this the first time around with Trump. So we continue to suffer in this sector while this war plays out and oil becomes unhinged. I am not sure how much more tone deaf Trump can be; he actually has the audacity this morning to suggest high oil prices are good for the country. It's fucking impossible to keep up with all the bullshit coming out of this government...or the previous government as well for that matter when it comes S3. Simple fact is DEA and FDA are either incompetent, or slow walking this on purpose regardless of whether the Democrats or Republicans are in charge. Just painful. If ever there was a time for Bondi to announce S3, it would be now. But this sector is pretty much past the point of any meaningful returns. That VFF is down 10 percent today is another testament to how screwed up this sector is. VFF is one of the most solid LPs out there. Nothing is making sense to me.

gdren

HITI is a retailer so while their sales are higher, their margins are lower because they need to buy products from companies like VFF to sell. VFF makes way more money from their sales. You can't compare revenue for retailers vs producers

FoodCooker62

Well I own both so no diss to high tide but even after the 800% runup from april lows VFF's valuation is pretty undemanding. Even before the current expansions going on they had $60 million of operating cash flow for the year. The balance sheet is very strong with a little over $2 per share of tangible book value, a large part of which consists of either cash & receivables or high quality greenhouse infrastructure. Substracting the TBV from the share price leaves $1.30 which one is paying for the earnings power ($60M OCF, $48M adj. EBITDA, and $21M net income from continuing operations) which is unmatched among cannabis stocks and a very reasonable price to pay for a strong and growing enterprise.

the_mammynun

Look great but VFF is one of the few companies in the sector who has already had a deserved and massive run up in share price. Why would I pay 2x sales on VFF when I can pay 0.4x sales for HITI? End of day VFF is a grower albeit an efficient one.. I think there are bigger opportunities at steeper discounts.

tstrand1204

VFF earnings call provided good explanation of quarterly sequential decline. Hopefully investors listening. Demand far outstrips supply and they’re investing from operating cash flow to meet that demand

Tzidda

VFF down hard pre market

NoOcelot

$0.04 EPS is the number to beat. We'll also learn how many shares were repurchased. MSOS added more VFF recently so that bodes well.

Russticale

VFF earnings tomorrow.  Who’s goin in?  Chart looks ready, im in with calls $3 and $4 usd weeklies

confidentbeaver

VFF will be the winner in the sea of shitty Canadian LPs

Forest_City_Frolfer

XLY, VFF, LOVE I'm invested in ROMJ, DB, CRON - ones I'm watching

Jules337x

VFF earnings in 8 days.

SwordfishOk504

VFF, Cronos, Aurora, Aphria, maybe OGI

FoodCooker62

 The CBD space has been gutted and commoditized and from what I have seen, BHB has managed to hold the line better than most. So i do give the BHB team props for making the best of it and if the CBD space gets a new lease on life through Trump's initiative, I do believe that BHB has a better chance than most of reinvigorating the business.  But for my long-VFF thesis, in my mind i have written these assets off completely. I assign more value to even VFF's energy section.  I do think the BHB episode has been a humbling experience for management though. Just wish the lesson wasnt so expensive. Share price would have never reached 50 cents if they kept that $70m on the balance sheet. But I am still a happy shareholder, there are no flawless management scorecards for any company in this sector  

FoodCooker62

Cost them $70M Usd and expected growth didnt materialize. Comparing to HITI's CBD business as a comparison... I will give props to VFF because BHB mostly had flat sales instead of full on implosion like HITI, so kudos to BHB management. But the goodwill writedowns poisoned the income statement for years. Hindsight is 20/20 but if they just diluted for cash and kept it over the years they would have avoided the disastrous share issuance of 2022 (which netted them only half of what BHB cost and caused warrant overhang until this very day) 

FoodCooker62

Thx for sharing. VFF acquisitions so far 1 hit (rose life science) and a miss (balanced health botanicals). Not counting the Leli acquisition since so small. I suppose the logic of buying a distributor makes sense, but it does increase exposure risk to Germany. Not sure what to think of it... suppose it would also depend on the price. But they do have a very strong foothold in the German market so I understand if they want to be more vertically integrated.

mfairview

VFF rumors http://stocktwits.com/Tomyboy11/message/646017700

hambone_83

Was looking forward to this print for one reason, this......*Fourth quarter 2025 International revenue of $51 million* Why? Because Boris has previously stated that they are VFF's largest customer as they buy mostly from them to fulfill their international needs. As for Curaleaf - nothing in this report makes me want to own the stock

Forest_City_Frolfer

I was in at $17.... Averaged down when they were 0.60 and got my avg cost down to $2.8 I started in the sector November 2020 with Aphria, VFF, HEXO and FIRE. Learned a lot since then, and didn't see green again till last year.

AverageNo130

Must have got in VFF after iit hit $15.00 in "21.

Forest_City_Frolfer

It's why I picked them! I've been in LOVE and VFF for years now and they've treated me well. XLY is a new pick for me. I wouldn't have touched them with a 10ft pole this time last year, but they really seem to have finished the turnaround and look really good now.

Forest_City_Frolfer

Did something new and decided to consolidate all my cannabis holdings. Instead of having a whole bunch of small positions. I now only have a very large position in Auxly, and a small position in VFF and LOVE. I previously had some HITI, some CRON, some GTI, some OILS, some ROMJ. But I think the best strategy is to pick the one you are the most confident in. We shall see how it goes when the annual fins for Auxly come out next month.

hambone_83

VFF is where I'm diverting some of my funds. I think it's a high likelihood they are chosen to participate in the CBD medicare program. They also have lots of other good things going on so if it doesn't happen I"m still comfortable holding them

Twist_of_Fate_44

That's not exactly true CWEB is by far the winner CRON and VFF are holding their own and at the same (or better) level as CGC

Fearless_fx

Ready for the sector to give up some gains tomorrow. OPEX pressure will be heavy and market makers will want to burn as many calls as they can. Usual shenanigans. That said, long term I’m still accumulating shares of VFF, GTII and TSND.

Orennji

Too early to tell. I'm 2x on my individual MSO holdings that I bought in 2024-2025. 3x on VFF. Bagholding on some OGI and micro caps, which I'll rebalance into MSOS if I don't see improvement. 

Tommygun194

VFF easyyyy.

Gambelero

Geo is right of course. Dilution is not the primary cause of CGC’s stock price resiliency. SNDL is worth a lot more now because they diluted whole hog at the top of their meme run. VFF was very smart to dilute at the end of the Texas hemp run-up.

Fearless_fx

VFF is moving steady sideways rather than just drilling into the ground. Glad they have their tomato and veggies business to diversify their profile. Otherwise they’d probably be -20% too on the day.

Difficult_Fig_1582

I have only lost 20,000 shares. Vie exercised. But I made a ton on it. VFF alone made me 300k last year.

Difficult_Fig_1582

So I do have 300,000 shares of VFF But only have 60,000 in covered calls. I do 1 mth out. And never do a call on earnings mths

Difficult_Fig_1582

I do calls on VFF. And UAN

FoodCooker62

Yeah, anxious to hear something as well. HITI will have another earnings report just over a month from now. Their core business works and they produce cash, so they can afford a few missteps. my hope (and my bet by holding these shares) is that they learned from their past mistakes and that now, hopefully forged by fire, they are taking another shot at expansion outside of their core market. But if this turns into another CBD or e-commerce misadventure I will likely sell my shares. Cant be long on a position where i dont trust management to responsibly manage my money, no matter how much is like the core brick&mortar business. I've been following the german market closely and there is still a lot of regulatory uncertainty with many aspects of the medical cannabis program. Its growing explosively, this is true, but there still remains tremendous uncertainty with regards to the framework in which these companies operate. Both of my cannabis holdings (HITI and VFF) have solid core businesses but got hosed by acquiring expensive (and ultimately worthless) CBD assets. This has directly muted my returns on these stocks so it sits deep with me. Just some rant like thoughts.

steph31199

pretty sure you meant VFF ? Maybe also try not to pump so hard ?

Unable_Brilliant6652

Yes, VFF number one in my books

Zarmit

VFF - financials are stellar since privatizing their Produce division. Expanding Canadian capacity 33% and Netherlands 400%.

FoodCooker62

From the top of my head a quick list of companies based on cash flow, a solid balance sheet, organic revenue growth, no excessive dilution:  Canada: HITI, VFF, Rubicon, Decibel, perhaps Auxly  US: GTBIF, TCNNF, perhaps Cresco.  There's almost certainly more but these are the ones i have some experience with analyzing. Im not well known wirh US MSOS. Avoid the meme names like CGC, TLRY like the plague. 

UsedState7381

Best MSO: GTBIF Best LP: VFF

Kbarbs4421

I call bullshit on that. Hile true in theory, its not true in practice. I've had accounts with Schwab for more than a decade now. Not once have any of the equities I hold been subject to such restrictions, and I've held some real sketchy shit at certain points. And these are some of the strongest companies in the sector with respect to balance sheets, reporting compliance, leadership, institutional investment, etc. CRON, VFF, SNDL. Meanwhile the underwater sketchy ass companies are still good. I get your point, but it's a bit disingenuous.

bourbonwarrior

Not a conspiracy, I have to call into Schwab to buy VFF and SNDL. Once purchased, I can direct the sell, but I am unable to secure shares without a broker, they are viewed as "restricted". This started, for me, about 10 trading days ago.

Kbarbs4421

That's what makes so little sense. The equities reportedly subject to this restriction (SNDL, VFF, and HITI) are among the lowest risk in the cannabis sector. Strange.

JoeMammy_1

I was going to buy some VFF last week but Schwab gave me the call in message. I was going to call in but then I thought, how many other VFF buyers will say fuck it I'm not calling in? Who wants a stock that's a bitch to buy?

bourbonwarrior

Yep, SNDL, VFF for example. Started about 10 trading days ago for me

Forest_City_Frolfer

I am also invested in Cannara, Rubicon and Auxly (and also VFF, and GTI) Auxly is my biggest position right now, I think they are the best value in the sector right now. Tangible Book Value 176M, Market Cap of 196M, and posting consistent profits. The thing that worries me is that I don't really see a downside, and that usually means I am missing something. But I think the only reason they are trading so low is because they were in a terrible financial position before Imperial bailed them out and they were really bad for dilution in previous years. To the point they have 1.3 Billion shares outstanding currently and they had 631 million shares in 2020. But they have really turned around and are no longer in a position where they should need to dilute anymore. So I think the very high share count, and how fast the price has jumped has scared people from jumping in and moving it higher at the moment. I expect as they continue to be consistently profitable the concerns around the share count will go away. Cannara is my old favourite. I've been in them since before the reverse split and I've been slowly picking up more. They look really good. I don't think they are in as good of a position as Auxly because they still need to build out a lot of capacity and keep growing marketshare. But they are consistently profitable. I was worried about their debt earlier, but with them resolving the convertible debentures they look really good. They had a stock option fluff a month ago, which I don't fully understand the significance of. I think they are pretty close to fairly valued right now, but they have been performing really well and don't see that changing anytime soon Rubicon Organics is the one I am a bit concerned about. They have incredible products, but I have been in them for a few years and I am down on them a bit (Cost basis 0.60). They were supply constrained and had no more capacity and were still not consistently profitable. Now they are building out the old Medipharm Labs facility they purchased, so they will have some expenses related to that. I expect them to lose money next year because of that. They will also have some risks associated with the additional costs of the new facility, so they will need to grow marketshare rather quickly to cover the expenses of the new facility. They have shown that they are more than capable, and I expect them to succeed, but I expect more patience with this one, and there are risks things can go wrong. Their balance sheet is in an okay spot, but they don't have as much wiggle room as the larger and better capitalized companies. So overall, I like all 3. My investment thesis for the past few years has been to target the profitable companies that are executing well in their niche. It seems to have started to work in 2025. I expect they will shine more in 2026 as they separate themselves from the pack more. They already know how to win, and with the ability to use cash from their operations to invest in growing the business, they are in a great position to win more.

halfbeerhalfhuman

wait till VFF has a bad Q. Ill be here first laughing at you... Jk i dont do that, im not a total POS

FoodCooker62

It's a meme stock in a meme sector. It can do anything. It is astounding that its worth as much as Auxly, VFF, OGI, HITI, Cannara and Decibel combined when any of these companies are operationally far stronger and more trustworthy. 

Forest_City_Frolfer

I currently track Canadian Cannabis companies. There's 25 publicly traded cannabis companies (that I could find) as of Dec 31,2025. There were 51 at the end of 2021. I think we lose 4 more (to bankruptcy and M&A) to finish with 21 at the end of the year, assuming none of the hundreds of private companies go public to increase that number. I think Canadian LPs that are profitable continue to do so and start to get more attention. (Auxly, VFF, Cannara, I'm sure there will be more that finally become profitable). I think nothing changes with Canadian Excise tax US wise it's hard to say. Performance is pretty reliant on US Politics and Trump is unpredictable. I just expect volatility without any real change.

Fearless_fx

The more research I do into VFF the more it makes me think it’s probably the most effective and diversified operator in the cannabis space right now… - $35M mortgage debt tied to greenhouse facilities worth ~10x the debt; no financial debt and they aren’t using their credit facility. - $88M cash on hand, so essentially no net debt. - $389M annual revenue; $10.8M quarterly net profit diversified between cannabis and greenhouse grown vegetables. - 5.5M square feet of Texas greenhouse ready to convert to cannabis pending licensing (hopefully April 2026) - Canadian operations cash flowing and 700%+ growth in European operations. - Already trades on NASDAQ. I wish I had just gone all in on VFF a year ago… it has to be one of the most impressive business turnaround stories in any sector in 2025. Might still drop off a cliff if it can’t get its Texas license in April, but if it does, I think it could quickly become one of the top MSOS by 2030 in terms of market share. Also needs Schedule 3 and for the NASDAQ to loosen rules on THC-touching assets though I suppose.

Fearless_fx

I’m just going to stick to buying VFF and GTI. Both seem to have solid management, significant cash on hand and are profitable. The only other speculative cannabis company I have in my portfolio is TerrAscend, which interests me since the CEO has such a big ownership stake, is cash flow positive, trades on the TSX and since Canopy US has optionality. I don’t like their debt ratio, but it may not matter once 280E is done and they become net profitable.

Difficult_Fig_1582

Dude. Invest in VFF. This time next year it will be double.

TomorrowLow5092

VFF is The Boss. Up 300% in one year with huge growth expected in 2026 across the globe.

Difficult_Fig_1582

VFF. Buying a ton of

Humungusminimaglight

There’s one to rule them all and that’s VFF.

Difficult_Fig_1582

Damn. You need VFF. Will double in 2026

Difficult_Fig_1582

https://preview.redd.it/dsy5wxmgbt9g1.jpeg?width=1179&format=pjpg&auto=webp&s=f4dde4539a73d1055982c1d44e87842d487aa5c3 All VFF and UAN.

Difficult_Fig_1582

VFF. 100% all day long. Will double in 2026.

Difficult_Fig_1582

VFF

Gambelero

I remember a day where VFF was up 10%, then down 10% and closed exactly to the penny where it started.